Bioengineered human trabecular meshwork for biological applications

1. A method for forming an artificial eye outflow system comprising the steps of:

(a) providing a wafer with an upper surface;

(b) applying a release layer to the upper surface of the wafer, thereby yielding a top surface;

(c) layering a substrate on the top surface;

(d) constructing a microstructured or nanostructured three-dimensional (3-D) SU-8 scaffold from the substrate, the 3-D SU-8 scaffold comprising a microstructured or nanostructured plurality of pores forming a patterned, porous grid structure having a porosity of greater than 20%, each pore of the plurality having:

a uniform pore size, wherein the uniform pore size is a size within a range, wherein the range is greater than 7 μm to 15 μm,

a first measurement (L 1 ) and a second measurement (L 2 ), both the first measurement (L 1 ) and the second measurement (L 2 ) of a size to prevent growth of trabecular network (TM) cells or Schlemm's canal (SC) cells within the pore, and

a set of four walls defining a 3-D pore shape, the set of four walls having a beam width (W) and a beam height (H),

wherein the constructing comprises using a mask to define the 3-D pore shape of each pore of the plurality to set a predetermined pore size and beam width size;

(e) releasing the 3-D SU-8 scaffold from the top surface;

(f) sterilizing the 3-D SU-8 scaffold;

(g) coating the 3-D SU-8 scaffold with a biocompatible coating to produce a coated 3-D SU-8 scaffold, wherein the biocompatible coating provides attachment for TM cells and/or SC cells;

(h) seeding the coated 3-D SU-8 scaffold with TM cells and/or SC cells at a pre-determined cell seeding density; and

(i) culturing the cells on the coated 3-D SU-8 scaffold for a period of time sufficient for the formation of a confluent monolayer on the surface of the coated 3-D SU-8 scaffold, such that an artificial trabecular meshwork is formed that mimics the perforated sheet-like structure, outflow facility, and physiological function of an in vivo trabecular meshwork.

2. The method for forming an artificial eye outflow system of claim 1 , further comprising the step of:

assessing cell morphology of the TM cells or SC cells.

3. The method for forming an artificial eye outflow system of claim 1 , wherein the beam width (W) is from about 0.1 μm to about 20 μm.

4. The method for forming an artificial eye outflow system of claim 3 , wherein the beam height (H) is from about 0.1 μm to about 20 μm.

5. The method for forming an artificial eye outflow system of claim 1 , wherein trabecular meshwork cells are cultured on a first side of the 3-D SU-8 scaffold and wherein Schlemm's canal cells are cultured on a second side of the 3-D SU-8 scaffold.

6. The method for forming an artificial eye outflow system of claim 5 , wherein the second side of the 3-D SU-8 scaffold is opposite the first side of the 3-D SU-8 scaffold.

7. The method of claim 1 , wherein the microstructured or nanostructured 3-D SU-8 scaffold is not in direct contact with the bottom of a cell culture plate.

8. The method of claim 1 , wherein the uniform pore size is 10-12 μm.

9. An artificial eye outflow system comprising:

a micro- and/or nanofabricated 3-dimensional (3-D) SU-8 scaffold, the 3-D SU-8 scaffold comprising a microstructured or nanostructured plurality of pores forming a patterned, porous grid structure having a porosity of greater than 20%, each pore of the plurality having:

a uniform pore size, wherein the uniform pore size is a size within a range, wherein the range is greater than 7 μm to 15 μm,

a first measurement (L 1 ) and a second measurement (L 2 ), both the first measurement (L 1 ) and the second measurement (L 2 ) of a size to prevent growth of trabecular meshwork (TM) or Schlemm's canal (SC) cells within the pore, and

a set of four walls defining a 3-D pore shape, the set of four walls having a beam width (W) and a beam height (H); and

wherein the 3-D SU-8 scaffold is covered with a confluent monolayer of TM cells or SC cells, such that the system mimics the perforated sheet-like structure, outflow facility, and physiological function of an in vivo trabecular meshwork.

10. The artificial eye outflow system of claim 9 , wherein the uniform pore size is 10-12 μm.

11. An in vitro system for high-throughput screening in a multi-well plate of pharmacological agents affecting intraocular pressure and trabecular outflow comprising:

(a) the artificial eye outflow system of claim 9 ;

(b) a perfusion chamber comprising a housing with a controlled environment chamber maintained at a constant temperature and flow rate; and

(c) a multi-channel perfusion array comprising:

a first element, wherein the first element comprises a multi-well plate insert, wherein the multi-well plate insert holds the artificial eye outflow system;

a second element comprising a bottom multi-well plate, wherein the bottom multi-well plate is an effluent collector;

a third element comprising a top multi-well plate, and a perfusion media inlet fluidly connected to the top multi-well plate, and wherein the first element is sandwiched between the second element and the third element; and

a fourth element, wherein the fourth element comprises an artificial eye outflow system holder wherein the artificial eye outflow system holder;

separates the first element from the artificial eye outflow system, and

prevents the artificial eye outflow system from touching the bottom multi-well plate.

12. The in vitro system of claim 11 further comprising:

a pressure transducer.

13. The in vitro system of claim 12 wherein the pressure transducer maintains a constant flow rate at about 0.1 μl/min to about 60 μl/min.

14. The in vitro system of claim 11 comprising:

a pressure transducer having the ability to maintain a constant flow rate for trabecular meshwork cells at about 30 μl/min to about from 60 μl/min.

15. A method for high-throughput screening of an agent that modulates eye outflow comprising the steps of:

(a) providing the in vitro system of claim 11 ; and

(b) flowing media or fluid through the in vitro system, wherein the media or fluid comprises a test agent.

16. The in vitro system of claim 12 , wherein the pressure transducer is functionally connected to the scaffold holder.

17. The in vitro system of claim 16 , further comprising:

a monitor functionally connected to the pressure transducer.

18. The in vitro system of claim 16 , further comprising:

a perfusion media entry system functionally connected to the pressure transducer.

19. The in vitro system of claim 16 , further comprising:

an experimental agent media entry system functionally connected to the pressure transducer.